Valneva SE ADR (VALN)
$3.93 -$0.03 (-0.89%) 4:37 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$336.11M -
Day's Range
$3.86 - $3.96 -
Volume
34,462 -
52 Week Low / High
$3.82 - $10.99 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
VALN's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $18.75
- Target Price
Company News
-
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study — Sep 3rd, 2024
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study Tuesday, Valneva SE (NASDAQ:VALN) and Pfizer Inc. (NYSE:PFE) released immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$